An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...
Contrave and Wegovy are two prescription medications approved by the U.S. Food and Drug Administration (FDA) for weight loss, but their mechanisms of action are very different. Here, Forbes Health ...
If you have type 2 diabetes, your health care provider may recommend metformin or Mounjaro to help manage your blood sugar.
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
A U.S. senator is pressing pharmaceutical giant Merck over its patenting and pricing practices for the blockbuster cancer drug Keytruda, escalating congressional scrutiny of industry strategies that ...
Durable ZUMA-2 follow-up converted brexu-cel to traditional approval in r/r MCL, while sonrotoclax gained accelerated approval post-BTK inhibitor based on 52% ORR. Breast-cancer decisions expanded ...
Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an increasingly intertwined human-machine model moves closer to adoption in real-world ...
In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
About two-thirds of patients ages 40 and older with a common form of breast cancer might be able to forego chemotherapy—usually delivered intravenously—as part of their treatment plans. Image by ...
What Is It, and Why Does It Matter? The FDA has approved Welireg (belzutifan), a prescription oral medicine, to be used as an adjuvant therapy with Keytruda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results